- Home
- BRX vs LEGN Comparison
BRX vs LEGN Comparison
Compare BRX & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRX | LEGN |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 5.9B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BRX | LEGN |
|---|---|---|
| Price | $25.89 | $26.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | $30.08 | ★ $72.92 |
| AVG Volume (30 Days) | ★ 2.1M | 1.8M |
| Earning Date | 10-27-2025 | 11-12-2025 |
| Dividend Yield | ★ 4.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $1,346,289,000.00 | $909,045,000.00 |
| Revenue This Year | $7.16 | $68.68 |
| Revenue Next Year | $4.72 | $48.49 |
| P/E Ratio | $23.95 | ★ N/A |
| Revenue Growth | 5.75 | ★ 74.75 |
| 52 Week Low | $22.29 | $25.71 |
| 52 Week High | $30.13 | $45.30 |
Technical Indicators
Market Signals| Indicator | BRX | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 40.58 | 30.22 |
| Support Level | $25.96 | $25.71 |
| Resistance Level | $26.61 | $29.39 |
| Average True Range (ATR) | 0.45 | 1.46 |
| MACD | -0.01 | -0.23 |
| Stochastic Oscillator | 8.99 | 14.51 |
Price Performance
Historical ComparisonAbout BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.